Figure 1. Combination treatment of AZD1208 and Ponatinib in H-SB2-luc xenograft model, significantly suppressed leukemia burden as compared with vehicle-treated group.
Figure 1

Combination treatment of AZD1208 and Ponatinib in H-SB2-luc xenograft model, significantly suppressed leukemia burden as compared with vehicle-treated group.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal